HassanMariAlnuaimatMD

Pulmonology • Gainesville, FL

Critical Care Medicine

Professor of Medicine Director, Pulmonary Hypertension Program, Lung Transplant Program Cleveland Clinic Abu Dhabi, UAE

Join to view full profile

Dr. Alnuaimat is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Alnuaimat's full profile

Already have an account?

Office
1600 sw archer road
Hamouda Bin Ali Al Dhaheri St 59
Gainesville, FL 32610
Phone+1 352-273-8738

Education & Training

University of FloridaFellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2004
Bridgeport Hospital/Yale UniversityResidency, Internal Medicine, 1993 - 1997
University of Jordan Faculty of MedicineClass of 1989

Certifications & Licensure

FL State Medical License 2004 - 2025
VA State Medical License 1999 - 2014
NC State Medical License 1996 - 2001
CT State Medical License 1995 - 1997

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Clinical Trials to Reduce the Risk of Antimicrobial Resistance Start of enrollment: 2010 Sep 01
Terminated
Phase 2
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
Completed
Phase 3
Beraprost-314d Added-on to Tyvaso® (BEAT) Start of enrollment: 2013 May 31
Completed
Phase 3
Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH Start of enrollment: 2018 Jul 15
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

85 citations
Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study
John H. Beigel, Pablo Tebas, Marie-Carmelle Elie-Turenne, Ednan K. Bajwa, Todd Bell
The Lancet. Respiratory Medicine. 2017-06-01
74 citations
Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension.
Adriano R. Tonelli, Hassan Alnuaimat, Kamal K. Mubarak
Respiratory Medicine. 2010-04-01
47 citations
Combination therapy with oral treprostinil for pulmonary arterial hypertension: A double-blind placebo-controlled clinical trial
R. James White, Carlos Jerjes-Sánchez, Gisela Martina Bohns Meyer, Tomas Pulido, Pablo Sepúlveda
American Journal of Respiratory and Critical Care Medicine. 2020-03-15